Myasthenia gravis (MG) constitutes an autoimmune neuromuscular syndrome distinguished by fluctuating muscle weakness and premature fatigue onset. Contemporary developments spanning the past decade have delivered remarkable progress in medical understanding, facilitated by cutting-edge diagnostic methodologies and immunological breakthroughs that have transformed the healthcare sector into an...